Login/Sign Up
₹85.5*
MRP ₹95
10% off
₹80.75*
MRP ₹95
15% CB
₹14.25 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
Alcohol may increase the risk of side-effects and worsen the condition.
Pregnancy
Unsafe
COGNIPRIDE MP 1MG TABLET is a category C drug and may cause harmful effects to the unborn baby. So, it is used only when the benefits of this medicine outweigh the risks.
Breast Feeding
Unsafe
COGNIPRIDE MP 1MG TABLET should not be used in breastfeeding mothers as it may get secreted in the breast milk and cause unwanted effects in the nursing babies.
Driving
Caution
COGNIPRIDE MP 1MG TABLET may cause vision problems. So, do not drive or operate heavy machinery if you have any problems with your vision while using COGNIPRIDE MP 1MG TABLET.
Liver
Caution
COGNIPRIDE MP 1MG TABLET should be taken with caution in patients with liver diseases. The dose may have to be adjusted by your doctor.
Kidney
Caution
COGNIPRIDE MP 1MG TABLET should be taken with caution especially if you have a history of kidney diseases. The dose may have to be adjusted by your doctor.
Children
Caution
COGNIPRIDE MP 1MG TABLET is not recommended for use in children below 18 years of age.
Product Substitutes
About COGNIPRIDE MP 1MG TABLET
COGNIPRIDE MP 1MG TABLET belongs to the group of medications called ‘antidiabetic agents’ used in the treatment of Type 2 diabetes mellitus. Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (metabolizes glucose), or if produced, it cannot function properly in the body.
COGNIPRIDE MP 1MG TABLET is a combination of three medicines, namely: Metformin, Glimepiride, and Pioglitazone. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Glimepiride acts by increasing the amount of insulin released by the pancreas. Pioglitazone works by decreasing the amount of glucose released by the liver and also by improving the sensitivity of tissues towards insulin effects.
You should take this medicine as prescribed by your doctor. You may experience side-effects of such as nausea (feeling sick), vomiting (falling sick), diarrhea, headache, stomach ache, respiratory infection, weight gain, sweating, palpitations, and vision problems. Some patients experience decline in blood sugar levels lower than normal (hypoglycemia) resulting in sweating, dizziness, headache, confusion, feeling hungry, temporary changes in vision, uneasiness, irritability, and weakness. In such cases, seek medical attention immediately.
Do not take COGNIPRIDE MP 1MG TABLET if you are allergic to any of its contents. Do not use this medicine if you have heart failure, bladder cancer, or diabetic ketoacidosis (a complication of diabetes). COGNIPRIDE MP 1MG TABLET may cause ‘lactic acidosis’ (accumulation of lactic acid in the blood), which requires immediate medical attention. The risk increases if you are previously diagnosed with kidney or liver diseases. Do not consume alcohol (risk of lactic acidosis) or fast for prolonged periods (risk of hypoglycemia). Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Uses of COGNIPRIDE MP 1MG TABLET
Medicinal Benefits
COGNIPRIDE MP 1MG TABLET contains Metformin, Glimepiride, and Pioglitazone. COGNIPRIDE MP 1MG TABLET is given when single or dual therapy of hypoglycemic agents is not effective in diabetes patients. Metformin acts by decreasing liver glucose production and intestinal glucose uptake. Glimepiride acts by increasing the secretion of insulin by the pancreas. Pioglitazone works by decreasing the amount of glucose released by the liver and improving insulin sensitivity in muscle and fat.
Directions for Use
Side Effects of COGNIPRIDE MP 1MG TABLET
Drug Warnings
COGNIPRIDE MP 1MG TABLET should be used with caution in patients with heart diseases as it increases the risk of heart failure. COGNIPRIDE MP 1MG TABLET may cause ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body. Do not consume excess alcohol as it increases the risk of lactic acidosis. COGNIPRIDE MP 1MG TABLET may lower vitamin B12 levels, so it is recommended to take blood tests regularly to identify any vitamin deficiencies.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise
Recommended for a 30-day course: 3 Strips